CVCO Form 4: Director Buys 2,000 Shares at $141.16, Sells Two Lots at ~$483
Rhea-AI Filing Summary
Susan L. Blount, a director of Cavco Industries (CVCO), reported multiple transactions on 08/14/2025 that changed her holdings. She acquired 2,000 shares of common stock at an average price of $141.16 and sold two blocks of 1,000 shares each at $485.00 and $481.42 respectively. After these transactions she beneficially owned 3,126 shares directly, which includes 290 shares underlying restricted stock units that are allocated but not yet vested or delivered. The filing also reports a non-employee director stock option covering 2,000 shares with a $141.16 exercise price that is exercisable and expires on 01/08/2026.
Positive
- Transparent disclosure of multiple insider transactions and option details for a director on 08/14/2025
- Acquisition of 2,000 common shares at an average price of $141.16 was reported
- Outstanding director option covering 2,000 shares with a $141.16 exercise price exercisable and expiring 01/08/2026 was disclosed
- Clear explanation that 290 shares are underlying RSUs allocated but not yet vested or delivered
Negative
- None.
Insights
TL;DR: Director executed option-related acquisition and concurrent high-price sales, modestly reducing direct holdings.
The report shows a mix of acquisition and disposals on the same date: a 2,000-share acquisition at a $141.16 average price and two 1,000-share dispositions at substantially higher prices ($485.00 and $481.42). Post-transaction direct beneficial ownership is 3,126 shares, including 290 unvested RSU shares. The presence of an outstanding director option for 2,000 shares exercisable through 01/08/2026 with a $141.16 exercise price is confirmed. Overall, these are routine Section 16 transactions that update insider holdings and option status; there is no new compensation plan or extraordinary event disclosed.
TL;DR: Filing documents timely insider trades and option holdings; transactions appear compliant with disclosure rules.
The Form 4 documents multiple same-day transactions and provides the required explanatory details, including VWAP disclosure for the $481.42 sale tranche and note of 290 RSU shares allocated but unvested. The option terms are explicitly stated (exercise price $141.16, exercisable and expiring 01/08/2026). The signature by attorney-in-fact and the explanatory remarks meet standard procedural requirements. No governance irregularities, Section 16 exemptions, or plan-level changes are reported in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Employee Director Stock Option (Right to Buy) | 2,000 | $0.00 | -- |
| Exercise | Common Stock | 2,000 | $141.16 | $282K |
| Sale | Common Stock | 1,000 | $485.00 | $485K |
| Sale | Common Stock | 1,000 | $481.42 | $481K |
Footnotes (1)
- This transaction was executed in multiple trades at prices ranging from $481.10 to $482.63. The price reported reflects the volume weighted average sales price. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. Includes 290 shares underlying Restricted Stock Units allocated but not yet vested or delivered. These options became fully exercisable on January 8, 2023 and expire on January 8, 2026.
